Merck Scores Unexpectedly in Pneumococcal Vaccine Fight With Pfizer. What It Means for the Stocks.

Merck Scores Unexpectedly in Pneumococcal Vaccine Fight With Pfizer. What It Means for the Stocks.
·3 min read

The CDC's influential vaccines advisory committee recommended both Pfizer and Merck’s new pneumococcal vaccines for older adults, surprising analysts.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting